BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7001604)

  • 21. Comparison of two systemic antibiotics for the prevention of complications in elective colorectal surgery.
    Antonelli W; Borgani A; Machella C; Morri F; Parrino A; Poloni M; Sbriccoli A
    Ital J Surg Sci; 1985; 15(3):255-8. PubMed ID: 3905700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.
    Drusano GL; Warren JW; Saah AJ; Caplan ES; Tenney JH; Hansen S; Granados J; Standiford HC; Miller EH
    Surg Gynecol Obstet; 1982 May; 154(5):715-20. PubMed ID: 7041297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cefoxitin, a new partly synthetic cephamycin antibiotic].
    Jotzoff M
    Med Welt; 1979 Jan; 30(4):147-9. PubMed ID: 310940
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with cefoxitin in surgical sections of intensive care wards].
    Mingolla F; Feliciotti F
    Chir Ital; 1982 Jun; 34(3):404-16. PubMed ID: 6765343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative studies of cefoxitin and cephalothin: an overview.
    Neu HC
    Rev Infect Dis; 1979; 1(1):144-51. PubMed ID: 400931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of cefotetan versus cefoxitin plus metronidazole in the treatment of gynecological infections.
    Schwiersch U; Lang N
    Chemioterapia; 1987 Jun; 6(2 Suppl):541-2. PubMed ID: 3334618
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical studies of cefoxitin on bacterial infection in severe blood diseases (author's transl)].
    Nakao I; Hasegawa S; Yasumizu M
    Jpn J Antibiot; 1981 Aug; 34(8):1185-90. PubMed ID: 7321197
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with cefoxitin sodium in extensive trials.
    Mogabgab WJ; Alvarez S; Beville RB
    J Antimicrob Chemother; 1978 Jul; 4(B):215-8. PubMed ID: 357390
    [No Abstract]   [Full Text] [Related]  

  • 29. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of cefoxitin in the treatment of infections in the surgical field (author's transl)].
    Hirayama T; Kikuchi K; Chiba K
    Jpn J Antibiot; 1980 Jul; 33(7):716-9. PubMed ID: 7452910
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical study on a new synthetic cephalosporin (cephalothin) in surgical patients].
    Naranjo Gómez A; de la Torre Carrasco F
    Rev Clin Esp; 1975 Mar; 136(6):537-42. PubMed ID: 1094506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cefoxitin and the kidney: pharmacokinetics and therapeutic results].
    Albertazzi A; Spisni C; Cappelli P; Del Rosso G; Di Paolo B; Palmieri P; Evangelista M
    G Clin Med; 1981 Dec; 62(12):874-82. PubMed ID: 7341305
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sodium cefoxitin in urology. Polycentric clinical study].
    Lotti T; Altieri A; Baccarani P; Bono A; Cristiano P; Di Donna D; Fabris P; Lelli A; Miano L; Mirone V; Nicolao M; Piazza B; Prosperi F; Rizzo F; Rizzo M; Rosi F; Salvia G; Tizzani A; Traversa GB; Usai E
    Minerva Urol; 1982; 34(4):251-5. PubMed ID: 7167143
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
    White JS; Gee C; Ledger WJ
    J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy.
    Engel K; Schmidt W; Sonntag HG; Kees F
    J Chemother; 1989 Jul; 1(4 Suppl):1053-6. PubMed ID: 16312768
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cefoxitin: its role in the therapy of anaerobic infections].
    Carvalho A; Fonseca C; Falcão F; Ceia F
    Acta Med Port; 1993 Oct; 6(10):467-71. PubMed ID: 8285118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin.
    Wilson SE
    J Chemother; 1989 Jul; 1(4 Suppl):820-2. PubMed ID: 16312655
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefoxitin sodium therapy of anaerobic infections.
    Busch DF; Heseltine PN; Meyer RD; Sutter VL; Finegold SM
    J Antimicrob Chemother; 1978 Jul; 4(B):197-202. PubMed ID: 357386
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with intravenous cefoxitin sodium in obstetrics and gynaecology.
    Sweet RL; Hadley KW; Mills J; Robbie M
    J Antimicrob Chemother; 1978 Jul; 4(B):249-50. PubMed ID: 357397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.